Product NDC: | 25021-816 |
Proprietary Name: | Leucovorin |
Non Proprietary Name: | leucovorin calcium |
Active Ingredient(s): | 350 mg/17.5mL & nbsp; leucovorin calcium |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 25021-816 |
Labeler Name: | Sagent Pharmaceuticals |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA200855 |
Marketing Category: | ANDA |
Start Marketing Date: | 20120915 |
Package NDC: | 25021-816-30 |
Package Description: | 1 VIAL in 1 CARTON (25021-816-30) > 17.5 mL in 1 VIAL |
NDC Code | 25021-816-30 |
Proprietary Name | Leucovorin |
Package Description | 1 VIAL in 1 CARTON (25021-816-30) > 17.5 mL in 1 VIAL |
Product NDC | 25021-816 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | leucovorin calcium |
Dosage Form Name | INJECTION, POWDER, FOR SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 20120915 |
Marketing Category Name | ANDA |
Labeler Name | Sagent Pharmaceuticals |
Substance Name | LEUCOVORIN CALCIUM |
Strength Number | 350 |
Strength Unit | mg/17.5mL |
Pharmaceutical Classes | Folate Analog [EPC],Folic Acid [Chemical/Ingredient] |